This segment highlights stocks on the emerging market that have seen notable developments. PowerX announced orders for stationary energy storage systems, Retty attracted attention with a catalyst for a sharp rise, and Kringle Pharma reported clinical trial-related developments in the United States. Related developments involving 犬猫生活 and others are also covered.
A program reviewing developments in the emerging market reported that PowerX had announced orders for stationary energy storage systems. The order value was reported to be ¥4.854 billion and was cited as an indication of demand trends at the company.
Retty was reported to have risen 44.5%, amid information that the Prime Minister was considering measures to support the restaurant industry, including the use of premium vouchers. The possibility of a consumption tax cut is believed to be behind the move.
Kringle Pharma was reported to have received an effective U.S. clinical trial application for a spinal cord injury treatment. The company is said to be progressing toward completion of the U.S. FDA review and preparations for a Phase 3 clinical trial.
The program also covered declining stocks and trading value rankings as part of its review of trends on the Tokyo Stock Exchange Growth Market. The commentators provided a detailed explanation of developments in the emerging market.